Listen & Subscribe

Get The Latest FutureTech News Delivered Right To Your Inbox

Over 100 million Americans suffer from chronic pain, which is more than the number of people suffering from cancer, diabetes, and heart disease combined. Considering this statistic, the current opioid epidemic isn’t terribly surprising. And even over-the-counter medications have a variety of side effects that can lead to kidney, liver, and GI issues over time. For many of these people, there’s a solution: Quell 2.0, a completely drug-free, wearable device that blocks lower-extremity pain signals by stimulating nerves with high-frequency electrical stimulation. No bigger than the size of a credit card, the device is worn comfortably and discretely around the calf and is the only over-the-counter therapeutic pain device that’s been FDA-cleared for use while sleeping. This is important since there is a positive feedback loop between pain and sleep; pain leads to loss of sleep, and sleep loss leads to the exacerbation of pain.

Frank McGillin, COO of Quell, joins the podcast to discuss all the details of how the product works, feedback from chronic pain patients who’ve used it, how long it takes to start working, the device’s ability to track quality of life measures to provide users with useful information over time, and the soon-to-be-launched AI-assisted Quell product that utilizes years’ worth of data to make the device smarter and more personalized to the individual pain sufferer.

Interested in learning more or getting one for yourself? Tune in and visit quellrelief.com.

Accessibility Close Menu
× Accessibility Menu CTRL+U